This HTML5 document contains 143 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
n8http://dx.doi.org/10.1136/
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q34453811
rdf:type
wikibase:Item
schema:description
სამეცნიერო სტატია ২০১২-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ מאמר מדעי 2012年论文 bài báo khoa học 2012年論文 tieteellinen artikkeli bilimsel makale 2012年论文 научна статия artigo científico (publicado na 2012) scienca artikolo vitenskapelig artikkel επιστημονικό άρθρο articol științific 2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած tudományos cikk 2012年の論文 article científic article scientifique (publié 2012) 2012 nî lūn-bûn artigo científico мақолаи илмӣ 2012年论文 vedecký článok wissenschaftlicher Artikel سائنسی مضمون บทความทางวิทยาศาสตร์ vitskapeleg artikkel article scientific 2012年论文 naučni članak artikull shkencor vědecký článek teaduslik artikkel artículo científico publicado en 2012 научная статья 2012年論文 2012년 논문 наукова стаття, опублікована в жовтні 2012 научни чланак artykuł naukowy 2012年論文 مقالهٔ علمی 2012年论文 мақолаи илмӣ 2012年论文 vetenskaplig artikel wetenschappelijk artikel videnskabelig artikel (udgivet 2012) articolo scientifico 2012 թվականի հոտեմբերին հրատարակված գիտական հոդված 2012年論文 научни чланак scientific article 2012年論文 artikulong pang-agham artigo científico (publicado na 2012) artículu científicu espublizáu en 2012 مقالة علمية mokslinis straipsnis
p:P577
wds:Q34453811-D7F2B675-B8E2-4CCF-9ACE-9DCB0916B6B8
wdt:P577
2012-10-18T00:00:00Z
p:P2860
wds:Q34453811-1A69F1AD-E619-433E-8DD9-84FC32DC4D93 wds:Q34453811-34020B0F-1A08-4F10-A894-85C851083E42 wds:Q34453811-3856DB26-1430-4A54-8883-1191C3B9FD30 wds:Q34453811-4149B3C1-ED28-4C62-88E0-185130F7759E wds:Q34453811-0E6C8040-BDA7-4291-A015-147CCB955AC3 wds:Q34453811-9CAB6276-81DC-468C-A18A-8AF7BD4D622F wds:Q34453811-A1ABD50A-F313-48E7-8AAE-55E33CF5AA5F wds:Q34453811-A58FE8CF-1CDF-4C32-A0AD-62BE545BB364 wds:Q34453811-AEA08C73-E113-4AE1-B017-AFE60DFDCFFD wds:Q34453811-BAD11518-EDB0-4C7F-9269-4C49DBA9B607 wds:Q34453811-BB03D48C-C281-4BE2-8E08-F4CC4C8D03B1 wds:Q34453811-C4F5ED29-4915-4D24-B9B8-121CD9551BF3 wds:Q34453811-552F5201-3B2D-4E15-856E-38A494812AFA wds:Q34453811-60B7D700-15CF-48F9-8C8D-066FE3FD3272 wds:Q34453811-677D49B4-2B06-45D4-981E-C85AE32010C5 wds:Q34453811-E7DB4D5A-DA5D-44C2-A043-FCA2DCC0A065 wds:Q34453811-FA2FA280-D597-4D9E-BC3D-491E145EFDE9
wdt:P2860
wd:Q36047253 wd:Q43924876 wd:Q46171594 wd:Q35179843 wd:Q42977474 wd:Q42977455 wd:Q51335341 wd:Q29547453 wd:Q44653784 wd:Q34227891 wd:Q28211392 wd:Q51372081 wd:Q33636992 wd:Q29614193 wd:Q51359456 wd:Q33874163 wd:Q37319128
p:P2093
wds:Q34453811-72F8391A-7A01-43E5-B805-5D139D383ECA wds:Q34453811-3F0D2167-978E-4D83-9DD7-F522E3CE8DDA wds:Q34453811-1B59FCEE-1CFD-4D32-888C-13763AD0DDAE wds:Q34453811-DB9F6376-1E38-4BDD-ACEE-E992ACFDF307
wdt:P2093
Christine Clar James Alexander Gill Rachel Court Norman Waugh
rdfs:label
Systematic review of SGLT2 receptor inhibitors in dual or triple therapy in type 2 diabetes Systematic review of SGLT2 receptor inhibitors in dual or triple therapy in type 2 diabetes Systematic review of SGLT2 receptor inhibitors in dual or triple therapy in type 2 diabetes
skos:prefLabel
Systematic review of SGLT2 receptor inhibitors in dual or triple therapy in type 2 diabetes Systematic review of SGLT2 receptor inhibitors in dual or triple therapy in type 2 diabetes Systematic review of SGLT2 receptor inhibitors in dual or triple therapy in type 2 diabetes
schema:name
Systematic review of SGLT2 receptor inhibitors in dual or triple therapy in type 2 diabetes Systematic review of SGLT2 receptor inhibitors in dual or triple therapy in type 2 diabetes Systematic review of SGLT2 receptor inhibitors in dual or triple therapy in type 2 diabetes
p:P1476
wds:Q34453811-53C2684F-7FD3-4195-AAA3-F964D9EF0EF0
wdt:P1476
Systematic review of SGLT2 receptor inhibitors in dual or triple therapy in type 2 diabetes
p:P31
wds:Q34453811-14643FA3-D97A-4602-ADE0-D1FE8D13F3C8
wdt:P31
wd:Q13442814
p:P921
wds:Q34453811-6AD93117-6E23-4996-A77C-15489998684C wds:Q34453811-DBEDC469-D860-48AB-8287-0D3D79EA2EA0 wds:Q34453811-043B4823-DD18-4C87-841A-C8615C85F4D0 wds:Q34453811-50926070-4F75-4BB9-A29F-50B6548566B0
wdt:P921
wd:Q47495780 wd:Q5030940 wd:Q1504425 wd:Q3025883
p:P698
wds:Q34453811-9A11E409-436C-4423-9AD5-52B18F780A0E
wdtn:P698
n12:23087012
wdt:P698
23087012
p:P1433
wds:Q34453811-7BFFB7B3-A166-4D9F-B4F7-1ADE615D9CEF
wdt:P1433
wd:Q17003470
p:P433
wds:Q34453811-0CCB542C-CCC4-4D16-B314-162A2838BCAB
p:P478
wds:Q34453811-F46DC92C-AC3C-447C-8009-8FEEFE510813
wdt:P433
5
wdt:P478
2
p:P356
wds:Q34453811-FA202279-6A2B-48DE-942A-7281B44D5FAE
wdtn:P356
n8:BMJOPEN-2012-001007
wdt:P356
10.1136/BMJOPEN-2012-001007
p:P5875
wds:Q34453811-4A278874-AFAE-43C3-9272-50EE9F6460E0
wdt:P5875
232534911
p:P932
wds:Q34453811-13D91114-FE2E-420B-A243-CF299AAE42C2
wdt:P932
3488745